AstraZeneca Invests $2 Billion to Develop New Cancer Treatments with Summit Therapeutics
AstraZeneca, a leading pharmaceutical company, has partnered with US-based Summit Therapeutics to speed up the development of new cancer treatments. […]
AstraZeneca, a leading pharmaceutical company, has partnered with US-based Summit Therapeutics to speed up the development of new cancer treatments. […]
Researchers in Japan have developed an innovative bioreactor that can turn waste from pharmaceutical and other biomanufacturing processes into energy.
The U.S. Food and Drug Administration (FDA) has published a new rule that encourages the use of modern, non-animal testing
Ethiopia, Norway, and the United Kingdom have promised to donate a total of $240 million to support CEPI’s new five-year
Grünenthal, a pharmaceutical company, has agreed to purchase Stivarga, an oral medication used to treat advanced cancers, from Bayer AG.
A new testing method, called gas chromatography, is being introduced to help make sure children’s medicines in Europe are safe
This week in pharmaceutical news, we saw important updates on vaccines, major deals in the industry, ambitious plans from China,
A new medication called tozorakimab has shown encouraging results in two large clinical trials (OBERON and TITANIA) that could change
A leading global vaccine maker, CSL Seqirus, has shared exciting news about a new flu vaccine designed specifically for adults
The contract development and manufacturing organization (CDMO) Lonza is building a new large-scale spray-drying facility in Bend, Oregon, USA. This